[Skip to Content]
[Skip to Content Landing]
July 21, 1962

Prevention of Airsickness with Meprobamate

Author Affiliations

Brooks Air Force Base, Tex.

JAMA. 1962;181(3):263-264. doi:10.1001/jama.1962.03050290085017c

WHILE the principal nervous pathways by which vestibular stimulation produces vomiting have been worked out, the mechanisms and sites of action of drugs effective in motion sickness are unknown. These drugs, without notable exception, are either belladonna alkaloids or antihistamines with central parasympatholytic properties. Despite the probable role of psychological factors in motion sickness, ataractic drugs tested under controlled conditions have been of little value. Since the tranquilizers tested thus far have all been of the autonomic type, we considered it of interest to examine meprobamate, a mild tranquilizer in wide use which is inactive at the autonomie level.

Methods Four hundred and forty-one unselected airmen, 17 to 20 years of age, with little or no flying experience, were tested in 16 flights in C-54 aircraft. Twelve to 32 volunteers, divided into 3 or 4 treatment groups, participated in each flight. Each group received either a lactose placebo (500 mg.),

Wang, S. C., and Chinn, H. I.:  Experimental Motion Sickness in Dogs: Functional Importance of Chemoceptive Emetic Trigger Zone ,  Amer J Physiol 178:111-116, 1954.
Wang, S. C., and Chinn, H. I.:  Experimental Motion Sickness in Dogs: Importance of Labyrinth and Vestibular Cerebellum ,  Amer J Physiol 185:617-623, 1956.
Chinn, H. I.:  Motion Sickness in Military Service ,  Mil Surgeon 108:20-29, 1951.
Chinn, H. I., and Smith, P. K.:  Motion Sickness ,  Pharmacol Rev 7:33-82, 1955.
Chinn, H. I., and Smith, P. K.:  Newer Therapy of Motion Sickness ,  Int Rec Med 168:13-22, 1955.
Gernandt, B. E., and Schmiterlow, C. G.:  Some Observations Concerning Mode of Action of Antihistamine Drug "Lergigan" (N(α-Methyl-β Dimethyl Amino Ethyl) Phenothiazine Hydrochloride) in Motion Sickness ,  Brit J Pharmacol 8:181-186, 1953.
Handford, S. W., et al.:  Drugs Preventing Motion Sickness at Sea ,  J Pharmacol Exp Ther 111:447-453, 1954.
Milch, L. J.; Frankl, H. D.; and Renzi, A. A.:  Effectiveness of Perphenazine and Systral Against Motion Sickness ,  J Appl Physiol 14:245-246, 1959.
 Report of Army, Navy, Air Force Motion Sickness Team: Evaluation of Drugs for Protection Against Motion Sickness Aboard Transport Ships ,  JAMA 160:755-760, 1956.Crossref
Trumbull, R., et al.:  Effect of Certain Drugs on Incidence of Seasickness ,  Clin Pharmacol Therap 1:280-283, 1960.
Unger, H. R., and Milch, L. J.:  Efficacy of Trilafon in Potentiating Bonamine Motion Sickness Prophylaxis in Dogs, School of Aviation Medicine , USAF, Report No. 59-78, (June) , 1959.
Berger, F. M.:  Chemistry and Mode of Action of Tranquilizing Drugs ,  Ann NY Acad Sci 67:685-700, 1957.Crossref
Chinn, H. I.; Milch, L. J.; and Dugi, A. J.:  Comparison of Various Drugs Against Airsickness ,  J Appl Physiol 6:257-259, 1953.
Chinn, H. I.:  Travel and Motion Sickness ,  Int Rec Med 168:523-527, 1955.
Friend, D. C.:  Current Concepts in Therapy: Tranquilizers. III. Meprobamate, Phenaglycodol and Chlordiazepoxide ,  New Engl J Med 264:870-873, 1961.Crossref
McGuire, T. F., and Leary, F. J.: Tranquilizing Drugs and Stress Tolerance, Wright Air Development Center Technical Report 58-64, 1958.
Zirkle, G. A.; McAtee, O. B.; and King, P. D.:  Meprobamate and Small Amounts of Alcohol: Effects on Human Ability, Coordination and Judgment ,  JAMA 173:1823-1825, 1960.Crossref